RN
ReNeuron Group plc
RNUGF · OTC
$0.00 +0.00% (+$0.00)
Market Cap £47.1K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.01x
P/S 0.09x
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 27.41%
Rev. growth 55.62%
FCF growth N/A
Profitability
0 /100
Weak Op. margin 1,342.45%
Gross margin 742.08%
FCF margin 1,453.58%
Quality
1 /100
Poor Asset turnover 0.05x
ROIC 105.51%
ROA 56.07%
Debt
69 /100
Low Int. coverage -331.85x
Debt/Equity 0.08x
Current ratio 2.05x
Stability
51 /100
Moderate EPS volatility 14.91%
Beta 1.04x
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre RNUGF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Iain Gladstone Ross
Employees
26
Headquarters
Pencoed
Evenimente viitoare
11 NOV.
Earnings
Upcoming earnings report